{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T08:25:20Z","timestamp":1774340720990,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jchromb.2022.123161","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T17:24:33Z","timestamp":1644341073000},"page":"123161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Ultrasensitive TLC determination of montlukast and loratadine mixture in human plasma utilizing fluorescence detection at dual pH values: Toward attaining separate maximum fluorescence intensity"],"prefix":"10.1016","volume":"1193","author":[{"given":"Ahmed A.","family":"Khorshed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma M.","family":"Abdelnaeem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayed M.","family":"Derayea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalia M.","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Oraby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jchromb.2022.123161_b0005","doi-asserted-by":"crossref","first-page":"S808","DOI":"10.1016\/S0091-6749(97)80040-1","article-title":"Prevalence of allergic rhinitis in the United States","volume":"99","author":"Nathan","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.jchromb.2022.123161_b0010","doi-asserted-by":"crossref","first-page":"S815","DOI":"10.1016\/S0091-6749(97)80041-3","article-title":"Quality of life and rhinitic symptoms: Results of a nationwide survey with the SF-36 and RQLQ questionnaires","volume":"99","author":"Meltzer","year":"1997","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jchromb.2022.123161_b0015","doi-asserted-by":"crossref","unstructured":"S.L. Spector, A.W. Group, Safety of antileukotriene agents in asthma management, Ann. Allergy, Asthma Immunol., 86 (2001) 18\u201323.","DOI":"10.1016\/S1081-1206(10)62307-1"},{"key":"10.1016\/j.jchromb.2022.123161_b0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0378-4347(01)00025-1","article-title":"Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma","volume":"754","author":"Al-Rawithi","year":"2001","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2022.123161_b0025","doi-asserted-by":"crossref","unstructured":"B. Knorr, J. Matz, J.A. Bernstein, H. Nguyen, B.C. Seidenberg, T.F. Reiss, A. Becker, P.M.S. Group, P.M.S. Group, Montelukast for chronic asthma in 6-to 14-year-old children: a randomized, double-blind trial, Jama, 279 (1998) 1181\u20131186.","DOI":"10.1001\/jama.279.15.1181"},{"key":"10.1016\/j.jchromb.2022.123161_b0030","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1007\/BF01978891","article-title":"Evaluation of the CNS properties of SCH 29851, a potential non-sedating antihistamine","volume":"14","author":"Barnett","year":"1984","journal-title":"Agents Actions"},{"key":"10.1016\/j.jchromb.2022.123161_b0035","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/030006058701500201","article-title":"Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis","volume":"15","author":"Bruttmann","year":"1987","journal-title":"J. Int. Med. Res."},{"key":"10.1016\/j.jchromb.2022.123161_b0040","series-title":"The Complete Drug Reference","author":"Martindale","year":"1999"},{"key":"10.1016\/j.jchromb.2022.123161_b0045","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jaci.2005.06.014","article-title":"Effect of combined montelukast and desloratadine on the early asthmatic response to inhaled allergen","volume":"116","author":"Davis","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jchromb.2022.123161_b0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3109\/09546634.2013.849791","article-title":"Efficacy of leukotriene receptor antagonist with anti-H1 receptor antagonist plus anti-H2 receptor antagonist for treatment of refractory chronic idiopathic urticaria","volume":"25","author":"Wan","year":"2014","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.jchromb.2022.123161_b0055","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1067\/mai.2000.106040","article-title":"Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial","volume":"105","author":"Meltzer","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jchromb.2022.123161_b0060","first-page":"45","article-title":"Development and validation of a HPLC method for the determination of montelukast and its degradation products in pharmaceutical formulation using an experimental design","volume":"53","author":"Eldin","year":"2011","journal-title":"Acta Pharmaceutica Sciencia"},{"key":"10.1016\/j.jchromb.2022.123161_b0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0378-4347(98)00179-0","article-title":"Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection","volume":"713","author":"Ochiai","year":"1998","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"issue":"4","key":"10.1016\/j.jchromb.2022.123161_b0070","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/0250-474X.27834","article-title":"A new liquid-liquid extraction method for determination of montelukast in small volume human plasma samples using HPLC with fluorescence detector","volume":"68","author":"Chauhan","year":"2006","journal-title":"Indian J. Pharmaceut. Sci."},{"key":"10.1016\/j.jchromb.2022.123161_b0075","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1556\/JPC.17.2004.1.17","article-title":"HPTLC determination of montelukast sodium in bulk drug and in pharmaceutical preparations","volume":"17","author":"Sane","year":"2004","journal-title":"JPC\u2013J. Planar Chromatogr.-Modern TLC"},{"key":"10.1016\/j.jchromb.2022.123161_b0080","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1039\/C8AN00772A","article-title":"Innovative HPTLC method with fluorescence detection for assessment of febuxostat\u2013montelukast combination and study of their protective effects against gouty arthritis","volume":"143","author":"Hosny","year":"2018","journal-title":"Analyst"},{"key":"10.1016\/j.jchromb.2022.123161_b0085","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/elan.201300077","article-title":"Differential pulse voltammetric determination of montelukast in tablets and human plasma by using chitosan modified carbon paste electrode","volume":"25","author":"Y\u0131ld\u0131z","year":"2013","journal-title":"Electroanalysis"},{"key":"10.1016\/j.jchromb.2022.123161_b0090","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jchromb.2004.06.022","article-title":"Rapid determination of loratadine in small volume plasma samples by high-performance liquid chromatography with fluorescence detection","volume":"809","author":"Amini","year":"2004","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jchromb.2022.123161_b0095","first-page":"123","article-title":"Determination of loratadine in human plasma by HPLC with fluorescence detector and study on its bioavailability, Yao xue xue bao=","volume":"39","author":"Xu","year":"2004","journal-title":"Acta pharmaceutica Sinica"},{"key":"10.1016\/j.jchromb.2022.123161_b0100","first-page":"830","article-title":"Determination of loratadine in human plasma by HPLC with solid phase extraction method","volume":"25","author":"Liu","year":"2005","journal-title":"Chinese Journal of Hospital Pharmacy"},{"key":"10.1016\/j.jchromb.2022.123161_b0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0021-9673(01)00646-X","article-title":"Sensitive liquid chromatography\u2013tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma","volume":"914","author":"Sutherland","year":"2001","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jchromb.2022.123161_b0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.japna.2003.07.001","article-title":"Determination of loratadine in human plasma by liquid chromatography electrospray ionization ion-trap tandem mass spectrometry","volume":"34","author":"Salem","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123161_b0115","doi-asserted-by":"crossref","first-page":"S825","DOI":"10.1016\/j.arabjc.2012.12.014","article-title":"Development and validation of a stability indicating RP-TLC\/densitometric method for determination of Loratadine in bulk and in tablets","volume":"10","author":"Chavhan","year":"2017","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.jchromb.2022.123161_b0120","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1556\/JPC.25.2012.5.12","article-title":"Validated HPTLC method for simultaneous determination of loratadine and desloratadine in presence of Co-formulated drug","volume":"25","author":"Youssef","year":"2012","journal-title":"JPC\u2013J. Planar Chromatogr.-Modern TLC"},{"key":"10.1016\/j.jchromb.2022.123161_b0125","first-page":"161","article-title":"Simultaneous determination of loratadine and preservatives in syrups by thin-layer chromatography","volume":"19","author":"Popovi\u0107","year":"2007","journal-title":"Acta chromatographica"},{"key":"10.1016\/j.jchromb.2022.123161_b0130","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bmc.3033","article-title":"Thin layer chromatography\u2013densitometric determination of some non-sedating antihistamines in combination with pseudoephedrine or acetaminophen in synthetic mixtures and in pharmaceutical formulations","volume":"28","author":"El-Kommos","year":"2014","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jchromb.2022.123161_b0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-4347(94)80078-2","article-title":"Sensitive gas\u2014liquid chromatographic method for the determination of loratadine and its major active metabolite, descarboethoxyloratadine, in human plasma using a nitrogen\u2014phosphorus detector","volume":"657","author":"Johnson","year":"1994","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2022.123161_b0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0731-7085(02)00668-4","article-title":"Capillary electrophoresis determination of loratadine and related impurities","volume":"31","author":"Fernandez","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123161_b0145","first-page":"260","article-title":"Capillary zone electrophoresis determination of loratadine in tablets","volume":"59","author":"Miku\u0161","year":"2004","journal-title":"Die Pharmazie-An Int. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jchromb.2022.123161_b0150","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/bio.1294","article-title":"Stability-indicating micelle-enhanced spectrofluorimetric method for determination of loratadine and desloratadine in dosage forms","volume":"26","author":"Walash","year":"2011","journal-title":"Luminescence"},{"key":"10.1016\/j.jchromb.2022.123161_b0155","unstructured":"M. Walash, Stability-indicating micelle-enhanced spectrofluorimetric method for determination of loratadine and desloratadi, J.: J. Adv. Chem., 11."},{"key":"10.1016\/j.jchromb.2022.123161_b0160","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s10895-015-1656-4","article-title":"Determination of Some Non-sedating Antihistamines via Their Native Fluorescence and Derivation of Some Quantitative Fluorescence Intensity-Structure Relationships","volume":"25","author":"El-Kommos","year":"2015","journal-title":"J. Fluorescence"},{"key":"10.1016\/j.jchromb.2022.123161_b0165","first-page":"823","article-title":"Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma","volume":"60","author":"Alsarra","year":"2005","journal-title":"Die Pharmazie-An Int. J. Pharmaceut. Sci."},{"key":"10.1016\/j.jchromb.2022.123161_b0170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0731-7085(02)00650-7","article-title":"Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods","volume":"31","author":"Radhakrishna","year":"2003","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2022.123161_b0175","first-page":"379","article-title":"UV-Vis spectrophotometry and multivariate calibration method for simultaneous determination of theophylline, montelukast and loratadine in tablet preparations and spiked human plasma","volume":"15","author":"Hassaninejad-Darzi","year":"2016","journal-title":"Iranian J. Pharmaceut. Res.: IJPR"},{"key":"10.1016\/j.jchromb.2022.123161_b0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1556\/JPC.27.2014.3.8","article-title":"Application of high-performance thin-layer chromatography for screening and simultaneous determination of some angiotensin II receptor antagonists in dosage forms and plasma","volume":"27","author":"Hussein","year":"2014","journal-title":"JPC-J. Planar Chromatogr.-Modern TLC"},{"key":"10.1016\/j.jchromb.2022.123161_b0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5740\/jaoacint.14-179","article-title":"HPTLC with fluorescence densitometry for simultaneous determination of some angiotensin II receptor blockers in tablets and plasma","volume":"98","author":"Hussein","year":"2015","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.jchromb.2022.123161_b0190","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1556\/JPC.28.2015.1.13","article-title":"Development of two high-performance thin-layer chromatographic methods for the determination of irbesartan in tablets and plasma","volume":"28","author":"Hussein","year":"2015","journal-title":"J. Planar Chromatogr.-Modern TLC"},{"key":"10.1016\/j.jchromb.2022.123161_b0195","article-title":"Innovative TLC-densitometric method with fluorescent detection for simultaneous determination of ternary anti-diabetic mixture in pharmaceutical formulations and human plasma","volume":"165","author":"Abbas","year":"2021","journal-title":"Microchem. J.106131"},{"key":"10.1016\/j.jchromb.2022.123161_b0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.talanta.2017.08.051","article-title":"Innovative thin-layer chromatographic method combined with fluorescence detection for specific determination of Febuxostat: Application in biological fluids","volume":"176","author":"Mohamed","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.jchromb.2022.123161_b0205","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1515\/chem-2018-0050","article-title":"Validated thin-layer chromatographic method for alternative and simultaneous determination of two anti-gout agents in their fixed dose combinations","volume":"16","author":"Mohamed","year":"2018","journal-title":"Open Chem."},{"key":"10.1016\/j.jchromb.2022.123161_b0210","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1093\/chromsci\/bmab019","article-title":"Innovative thin-layer chromatography\/fluorescence detection approach for sensitive and specific determination of ledipasvir in rats\u2019 feces and pharmaceutical dosage form","volume":"59","author":"Abdel-Lateef","year":"2021","journal-title":"J. Chromatogr. Sci."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222000654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023222000654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:07:32Z","timestamp":1761606452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023222000654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":42,"alternative-id":["S1570023222000654"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123161","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasensitive TLC determination of montlukast and loratadine mixture in human plasma utilizing fluorescence detection at dual pH values: Toward attaining separate maximum fluorescence intensity","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2022.123161","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123161"}}